Inpharmus participated in the SSIEM symposium meeting with representatives from Immedica Pharma.
Published
Signal category
Presence & Recognition
Quote
“During SSIEM, representatives from Inpharmus and Immedica Pharma met to discuss potential collaborations.”
— Inpharmus team
Company
- Industry
- Pharmaceutical Manufacturing
- Location
- Istanbul, TR
- Company size
- 87 employees
Inpharmus’s journey began in 2013 under the name TRPharm, and in 2025, we continue as Inpharmus, in line with our vision of becoming a global healthcare company. With offices in Istanbul and Dubai, we provide products and services to nearly 20 countries and maintain a physical presence in 12 of them. With our team of experts, we continue to make a difference in the healthcare industry, combining over 100 years of collective experience from our doctors and pharmacists with innovative business approaches and medical expertise. Together with our global partners, we create value across all stages of healthcare, from diagnosis to treatment. At Inpharmus, we are committed to valuing people, building strong and transparent partnerships, maintaining a balance between science, technology, and ethics, and driving continuous transformation to shape the future. We continue to innovate and make a lasting impact in the healthcare sector.
Founded 2013